含氟聚合物密封剂毒性:英国国家毒物信息服务2009-2015年报告
该研究回顾性分析了2009至2015年间英国国家毒物信息服务接到的101次电话咨询,涉及96次暴露,其中88次为气雾剂形式暴露,89次为单纯吸入。所有90例吸入暴露患者均出现临床症状,按PSS分级:31例为轻度(PSS 1),51例为中度(PSS 2),8例为重度(PSS 3)。最常见症状为呼吸困难(57.8%)、胸痛/胸闷(37.8%)、咳嗽(30.0%)和窦性心动过速(12.2%),低氧血症占22.2%。15例接受胸部X线检查,其中8例(均为PSS 3)报告异常,表现为双肺阴影。结论提示吸入含氟聚合物密封剂后可能出现临床症状,小部分(9%)为严重特征。
要点
- 所有90例吸入暴露患者均出现临床症状,其中8例(9%)为PSS 3级严重中毒。
- 最常见症状为呼吸困难(57.8%)、胸痛/胸闷(37.8%)、咳嗽(30.0%)和窦性心动过速(12.2%)。
- 低氧血症见于22.2%的吸入暴露患者。
- 15例接受胸部X线检查的患者中,8例(均为PSS 3)报告异常,表现为双肺阴影。
- 大多数暴露(88/96)为气雾剂形式,12例为职业暴露,其余为家庭使用。
适用人群与场景
- 通过电话咨询英国国家毒物信息服务的含氟聚合物密封剂暴露患者。
- 12例为职业暴露,其余为家庭使用产品时暴露。
- 89例为单纯吸入暴露,2例摄入,3例皮肤接触,1例眼接触,1例吸入合并眼接触。
诊断标准与关键阈值
- 中毒严重程度采用世界卫生组织/国际化学品安全规划署/欧洲委员会/欧洲毒物中心和临床毒理学家协会中毒严重度评分(PSS):PSS 1为轻度毒性,PSS 2为中度毒性,PSS 3为严重中毒。
红旗征与不能漏的情况
- 吸入暴露后出现呼吸困难、胸痛/胸闷、咳嗽、窦性心动过速或低氧血症,可能提示中度至重度中毒(PSS 2-3)。
- 胸部X线显示双肺阴影者均为PSS 3级严重中毒。
研究设计与关键结果
- 研究类型为回顾性分析,分析2009至2015年间英国国家毒物信息服务接到的电话咨询。
- 共101次咨询,涉及96次暴露;88次暴露为气雾剂递送密封剂。
- 所有90例吸入暴露患者均出现临床症状:31例PSS 1,51例PSS 2,8例PSS 3(严重中毒占9%)。
- 常见症状:呼吸困难52例(57.8%,95%CI 47.0-68.5),胸痛/胸闷34例(37.8%,95%CI 27.2-48.4),咳嗽27例(30.0%,95%CI 20.0-40.0),窦性心动过速11例(12.2%,95%CI 4.1-18.2),低氧血症20例(22.2%,95%CI 13.1-31.4)。
- 15例在咨询时已行胸部X线检查,其中8例(均为PSS 3)报告异常,显示双肺阴影。
证据类型、等级与局限
- 证据类型:回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,吸入含氟聚合物密封剂后可能出现临床症状,小部分(9%)特征可能严重。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
CONTEXT: Grout, tile and floor stone sealants contain a solvent, a water-repelling agent and in the case of aerosols a propellant. The water-repelling agent used is typically a fluoropolymer resin, a silicon-based resin, or a combination of both.
OBJECTIVE: To report the clinical course in patients exposed to fluoropolymer-containing sealants referred to the United Kingdom National Poisons Information Service.
METHODS: A retrospective analysis was performed of telephone enquiries received between 2009 and 2015.
RESULTS: 101 enquiries involving 96 exposures were received. The majority of the exposures (n = 88) occurred when the sealant was delivered from an aerosol. Twelve patients were exposed occupationally and the remainder were exposed while using the product at home. Eighty-nine exposures were as a result of inhalation alone, two followed ingestion, three skin contact and one eye contact; one involved inhalation and eye contact. All 90 patients exposed by inhalation developed clinical features: 31 had a World Health Organisation/International Programme on Chemical Safety/European Commission/European Association of Poison Centres and Clinical Toxicologists Poisoning Severity Score of 1 (minor toxicity), 51 patients had features of moderate toxicity (PSS 2) and eight were graded PSS 3 (severe poisoning). The most common features were dyspnea (n = 52; 57.8%; 95% CI = 47.0-68.5), chest pain/tightness (n = 34; 37.8%; 95% CI = 27.2-48.4), coughing (n = 27; 30.0%; 95% CI = 20.0-40.0) and sinus tachycardia (n = 11; 12.2%; 95% CI = 4.1-18.2); hypoxemia was present in 20 (22.2%; 95% CI = 13.1-31.4). At the time of the enquiry a chest X-ray had been performed on 15 patients: in eight patients (all of whom were PSS 3) the X-ray was reported as being abnormal and showed bilateral shadowing.
CONCLUSIONS: This study demonstrates that if fluoropolymer-containing sealants are inhaled then clinical features may occur and in a small proportion (9%) these features may be severe.
参考来源
- Henke D, Campbell A, Bradberry SM, et al. Toxicity from fluoropolymer-containing grout, tile and stone floor sealants reported to the UK National Poisons Information Service 2009-2015. Clin Toxicol (Phila). 2017. PMID: 28349783. doi:10.1080/15563650.2017.1296154
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。